Amgen, Inc. is a large American biopharmaceutical company that develops and sells medicines. Its filings show it lobbies Congress on Medicare and Medicaid drug payment rules (including Medicare Part B and Part D), drug pricing policies like Most-Favored-Nation proposals and pharmacy benefit manager reform, as well as tax rules affecting the drug industry, disease prevention policies, and budget matters. It reported about $240,000 in lobbying and used Williams & Jensen, PLLC.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CHRISTOPHER E. WILCOX
The latest disclosures for this client.
WILLIAMS AND JENSEN, PLLC
Q4WILLIAMS AND JENSEN, PLLC
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
WILLIAMS AND JENSEN, PLLC
DENIS DWYER
WILLIAMS AND JENSEN, PLLC
JEANNE HAGGERTY
WILLIAMS AND JENSEN, PLLC
mr CHRISTOPHER W HATCHER
WILLIAMS AND JENSEN, PLLC
ms MELINDA M MAXFIELD
WILLIAMS AND JENSEN, PLLC
SUSAN HIRSCHMANN
WILLIAMS AND JENSEN, PLLC
WILLIAMS AND JENSEN, PLLC
Q2WILLIAMS AND JENSEN, PLLC
Q1